In Brief This Week: Mirxes, Oncocyte, OpGen, Biodesix, Element Biosciences, More
August 11, 2023
Singapore, 15 May 2025 – Singapore-based medical testing firm Mirxes joins Jiangsu Hengrui Pharmaceuticals in revitalised market’s listing surge Initial public offering (IPO) plans keep rolling in for Hong Kong’s